ArticleCancer science2018

eIF2β, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer.

Ichidai Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.